Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.
about
Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'IvoireIncidence and predictors of first line antiretroviral regimen modification in western KenyaA decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy.Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters.Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America.Use of third line antiretroviral therapy in Latin AmericaAdverse drug reactions to antiretroviral therapy during the early art period at a tertiary hospital in GhanaIncidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort studyAntiviral resistance and correlates of virologic failure in the first cohort of HIV-infected children gaining access to structured antiretroviral therapy in Lima, Peru: a cross-sectional analysisEngagement in HIV care and sexual transmission risk behavior among men who have sex with men using online social/sexual networking in Latin AmericaThe Reason for Regimen Change Among HIV/AIDS Patients Initiated on First Line Highly Active Antiretroviral Therapy in Southern Ethiopia.Cancer in HIV-infected persons from the Caribbean, Central and South America.Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD.Adverse Drug Reaction Profile in Patients on Anti-tubercular Treatment Alone and in Combination with Highly Active Antiretroviral Therapy.Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients.Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America NetworkAntiretroviral Regimen Durability and Success in Treatment-Naive and Treatment-Experienced Patients by Year of Treatment Initiation, United States, 1996-2011Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America.Toxicity-related antiretroviral drug treatment modifications in individuals starting therapy: a cohort analysis of time patterns, sex, and other risk factors.[Risk factors associated with virologic failure in HIV- infected patients receiving antiretroviral therapy at a public hospital in Peru].Incidence and Predictors of Antiretroviral Treatment Modification in HIV-Infected Adults: A Brazilian Historical Cohort from 2001 to 2010.High incidence of hypertriglyceridemia in a Brazilian cohort of people living with HIV/AIDS undergoing antiretroviral treatment in Belo Horizonte, 2001-2010.Motives for change of first-line antiretroviral therapy regimens in an unselected cohort of HIV/AIDS patients at a major referral centre in South-west Cameroon.Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America.Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients.Reasons and predictors for antiretroviral therapy change among HIV-infected adults at South West Ethiopia.Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA).
P2860
Q28475790-C0D52E9C-FE0C-460D-B10D-2BE0A537DA9AQ28541822-658C53B4-EDC0-4EE9-8798-44CC9C681FE0Q33834625-C2C7B29E-4224-435A-827D-F4213C1C418EQ33921227-A3DB448A-2D37-40EA-988B-26659EE76E01Q34062163-EFEC4228-859E-4513-B380-5A83DA9C9437Q34183261-78DE639F-BF27-4B25-881A-3F52D578A5A0Q34427807-CF4C6FD7-9195-45FB-9096-949699296DA1Q34484483-530A5D64-C861-4DC6-9194-CDA07D0DB602Q34528801-0ACECF32-DB27-4BB4-BD8A-A78047EB800EQ35587308-74B3F8CE-16D5-4017-A574-1E26BCFE1AF3Q35787655-929B36AE-0255-457D-B98B-49052DCEAA0BQ35801613-79ABDF6B-229C-49F6-ABF9-F7144DEFE32BQ35810398-73DD2EC4-1369-4625-B01F-21F387290A31Q36221959-7234635D-842D-46A0-A331-89AC95D9B5E1Q36426953-AA2DB083-059F-44F7-8C03-3F6CCC449F0AQ36462119-509DC3BC-8DA7-4E9B-AD98-65827EF93AF8Q36463711-414DC595-2409-40B9-B66A-97FB2DA0BCDAQ36707987-48336F7C-A634-4D81-958E-53B06FA63E41Q36954711-BA320B2C-8FDE-49FA-8AE9-80F069B8AFBDQ37481106-DFDCEAC3-3B0E-4BB0-8828-575334F69411Q37699865-245079F3-46FB-4CAC-B404-646EEA97BEABQ39078112-54EA3E3E-B932-4550-AB39-E16D8F0873AEQ46867082-CDC86E33-EB4D-4F1A-983A-A6F28144F123Q52661543-86D0D91F-F447-4ECB-B69B-1F4AE48A7D69Q53835112-097E33C3-31A7-4A38-834F-89ABAEBD2941Q55257500-E88A9269-8023-4BF4-8253-6D34B1ADFE0DQ55425622-F3A27A81-DE4B-418B-BE49-125F4CCC6F88
P2860
Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Rates and reasons for early ch ...... e Caribbean and Latin America.
@ast
Rates and reasons for early ch ...... e Caribbean and Latin America.
@en
type
label
Rates and reasons for early ch ...... e Caribbean and Latin America.
@ast
Rates and reasons for early ch ...... e Caribbean and Latin America.
@en
prefLabel
Rates and reasons for early ch ...... e Caribbean and Latin America.
@ast
Rates and reasons for early ch ...... e Caribbean and Latin America.
@en
P2093
P2860
P50
P1433
P1476
Rates and reasons for early ch ...... e Caribbean and Latin America.
@en
P2093
Alejandro J Krolewiecki
Bryan E Shepherd
Caribbean, Central and South A ...... Evaluate AIDS (IeDEA) Program
Carina Cesar
Daniel R Masys
Eduardo Gotuzzo
Juan Sierra Madero
Mauro Schechter
Paul Leger
Pedro E Cahn
P2860
P304
P356
10.1371/JOURNAL.PONE.0010490
P407
P577
2010-06-01T00:00:00Z